Novel insights into the role of cardiotrophin-1 in cardiovascular diseases (Q37342253)

19 August 2017

1 reference

title

Novel insights into the role of cardiotrophin-1 in cardiovascular diseases (English)

1 reference

19 August 2017

main subject

cardiovascular disease

1 reference

P Calabrò

1 reference

19 August 2017

G Limongelli

1 reference

19 August 2017

L Riegler

1 reference

19 August 2017

V Maddaloni

1 reference

19 August 2017

R Palmieri

1 reference

19 August 2017

E Golia

1 reference

19 August 2017

T Roselli

1 reference

19 August 2017

D Masarone

1 reference

19 August 2017

G Pacileo

1 reference

19 August 2017

P Golino

1 reference

19 August 2017

R Calabrò

1 reference

19 August 2017

publication date

13 November 2008

1 reference

Journal of Molecular and Cellular Cardiology

19 August 2017

published in

1 reference

19 August 2017

1 reference

19 August 2017

1 reference

19 August 2017

page(s)

142-148

1 reference

The increasing impact of laboratory medicine on clinical cardiology

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Biomarkers of cardiovascular disease: molecular basis and practical considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Biomarkers of cardiovascular damage and dysfunction--an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Inflammatory biomarkers in acute coronary syndromes: part IV: matrix metalloproteinases and biomarkers of platelet activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Head-to-head comparison of BNP and IL-6 as markers of clinical and experimental heart failure: Superiority of BNP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Cardiotrophin-1: a new cardiac marker?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Cardiotrophin-1: a novel cytokine and its effects in the heart and other tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Cardiotrophin-1 phosphorylates akt and BAD, and prolongs cell survival via a PI3K-dependent pathway in cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Gp130-mediated pathway and left ventricular remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Acute-Phase Response Factor, a Nuclear Factor Binding to Acute-Phase Response Elements, is Rapidly Activated by Interleukin-6 at the Posttranslational Level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Cardiotrophin-1 and urocortin cause protection by the same pathway and hypertrophy via distinct pathways in cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Cardiotrophin-1 can protect cardiac myocytes from injury when added both prior to simulated ischaemia and at reoxygenation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Cardiotrophin-1 (CT-1) can protect the adult heart from injury when added both prior to ischaemia and at reperfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Hypertrophic responses to cardiotrophin-1 are not mediated by STAT3, but via a MEK5-ERK5 pathway in cultured cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Characterization of the protective effects of cardiotrophin-1 against non-ischemic death stimuli in adult cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

CT-1 mediated cardioprotection against ischaemic re-oxygenation injury is mediated by PI3 kinase, Akt and MEK1/2 pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

In vivo effects of cardiotrophin-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Cardiotrophin-1 is an essential factor in the natural defense of the liver against apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Cardiotrophin-1 alters airway smooth muscle structure and mechanical properties in airway explants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Effects of cardiotrophin on adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Cardiotrophin-1, a muscle-derived cytokine, is required for the survival of subpopulations of developing motoneurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Cardiotrophin-Like Cytokine/Cytokine-Like Factor 1 is an Essential Trophic Factor for Lumbar and Facial MotoneuronsIn Vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Human cardiotrophin-1: protein and gene structure, biological and binding activities, and chromosomal localization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

The heart is a source of circulating cardiotrophin-1 in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Cardiotrophin-1 (CT-1): a novel hypertrophic and cardioprotective agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Cardiotrophin-1 induces heat shock protein accumulation in cultured cardiac cells and protects them from stressful stimuli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Novel functional role of heat shock protein 90 in ATP-sensitive K+ channel-mediated hypoxic preconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Heat shock proteins and cardiac protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Cardiotrophin-1 stimulation of cardiac fibroblast growth: roles for glycoprotein 130/leukemia inhibitory factor receptor and the endothelin type A receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Induction of protein synthesis in cardiac fibroblasts by cardiotrophin-1: integration of multiple signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Effects of cardiotrophin-1 on haemodynamics and cardiac function in conscious rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Chronic cardiotrophin-1 stimulation impairs contractile function in reconstituted heart tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Effects of cardiotrophin-1 on hemodynamics and endocrine function of the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

A genetic locus accentuates the effect of volume overload on adverse left ventricular remodeling in male and female rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Mechanisms of cardiac fibrosis in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Hypertension, cardiotrophin-1 and gp130: three points to heart failure?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Increased expression of IL-6 and LIF in the hypertrophied left ventricle of TGR(mRen2)27 and SHR rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Plasma cardiotrophin-1 is elevated in human hypertension and stimulated by ventricular stretch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Is plasma cardiotrophin-1 a marker of hypertensive heart disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Association of Increased Plasma Cardiotrophin-1 With Inappropriate Left Ventricular Mass in Essential Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Usefulness of plasma cardiotrophin-1 in assessment of left ventricular hypertrophy regression in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

The effect of valvular regurgitation on plasma Cardiotrophin-1 in patients with normal left ventricular systolic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Plasma N-terminal pro BNP and cardiotrophin-1 are elevated in aortic stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Augmented cardiac cardiotrophin-1 in experimental congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Augmented expression of cardiotrophin-1 in failing human hearts is accompanied by diminished glycoprotein 130 receptor protein abundance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Relationship between plasma level of cardiotrophin-1 and left ventricular mass index in patients with dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Ventricular cardiotrophin-1 activation precedes BNP in experimental heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Plasma level of cardiotrophin-1 as a prognostic predictor in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Cardiotrophin-1: expression in experimental myocardial infarction and potential role in post-MI wound healing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Simvastatin attenuates hypertrophic responses induced by cardiotrophin-1 via JAK-STAT pathway in cultured cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

Simvastatin prevents cardiac hypertrophy in vitro and in vivo via JAK/STAT pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.002

10.1016/J.YJMCC.2008.11.002

7 January 2021

Identifiers

DOI

1 reference

19 August 2017

1 reference